Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Case Rep Orthop ; 2018: 7909184, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29854520

RESUMO

Treatment of displaced intra-articular fractures of the calcaneus remains a challenge for the orthopaedic surgeon. Conservative therapy is known to produce functional impairment. Surgical approach is plagued by soft-tissue complications and insufficient fracture reduction. We describe a minimally invasive technique that will hopefully improve these issues. We want to present our first experience through two cases. The first was a 46-year-old man who presented with a Sanders type IIBC calcaneal fracture, and the second was a 86-year-old woman with a type IIIBC calcaneal fracture. We introduced 2 Schanz screws in the talus and the calcaneus. After distraction, we introduced an inflatable balloon inside the calcaneus. By inflating the balloon, the articular surface was reduced by lifting it up. Then bone cement was injected in order to maintain the reduction. Additional screw fixation was used in the young patient. Postoperative imaging showed good congruence of the subtalar joint without leakage of cement, for the two cases. After 2 months, the patients had no pain and were without soft-tissue complications. We advocate this technique to perform a minimally invasive reduction and fixation of intra-articular calcaneal fractures because it preserves soft-tissues and provides good clinical results with early weight-bearing.

2.
Arch Biochem Biophys ; 371(2): 332-9, 1999 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-10545222

RESUMO

Glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a plasma enzyme with extensive sequence similarity to integrin alpha subunits, is inhibited by micromolar concentrations of lipid A, phosphatidic acid (PA) and lysophosphatidic acid (M. G. Low and K.-S. Huang, J. Biol. Chem. 268, 8480-8490, 1993). In this study we have explored the mechanism of inhibition using synthetic analogs of lipid A, and PA. Monosaccharide analogs of lipid A, which varied in the number and position of the phosphate groups, the type of acyl group, and its linkage to the glucosamine ring, were tested for their ability to inhibit GPI-PLD. A compound (SDZ 880.431) containing 3-aza-glucosamine 1,4-diphosphate as the polar headgroup was identified which had a potency (IC(50) approximately 1 microM) similar to natural lipid A preparations. Removal of either phosphate residue increased the IC(50) markedly. Analogs of PA such as (7-nitro-2-1,3-benzoxadiazo-4-yl)amino-PA, ceramide 1-phosphate, and hexadecyl phosphate had approximately IC(50) values ranging from 1 to 5 microM, indicating that considerable variation in the structure of the hydrophobic groups was permissible. Inhibition of GPI-PLD by long-chain PA could not be blocked by high concentrations of glycerol 1-phosphate or dibutyryl PA. These results indicate that the hydrophobic groups do not have a passive role in inhibition but are directly involved in the binding interaction with GPI-PLD. We propose that this diverse group of inhibitors all bind to a common site on GPI-PLD, the central hydrophobic cavity predicted by the beta-propeller model for integrin alpha subunits and GPI-PLD.


Assuntos
Lipídeo A/análogos & derivados , Monossacarídeos/farmacologia , Ácidos Fosfatídicos/farmacologia , Fosfolipase D/antagonistas & inibidores , 4-Cloro-7-nitrobenzofurazano/análogos & derivados , Animais , Relação Dose-Resposta a Droga , Relação Estrutura-Atividade , Trypanosoma brucei brucei , Glicoproteínas Variantes de Superfície de Trypanosoma/metabolismo
4.
Infect Immun ; 66(6): 2562-9, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9596717

RESUMO

Monocytes/macrophages play a central role in mediating the effects of lipopolysaccharide (LPS) derived from gram-negative bacteria by the production of proinflammatory mediators. Recently, it was shown that the expression of cytokine genes for tumor necrosis factor alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interferon-inducible protein-10 (IP-10) by murine macrophages in response to low concentrations of LPS is entirely CD14 dependent. In this report, we show that murine macrophages respond to low concentrations of LPS (

Assuntos
Proteínas de Fase Aguda , Citocinas/biossíntese , Lipídeo A/análogos & derivados , Lipopolissacarídeos/imunologia , Macrófagos/imunologia , Glicoproteínas de Membrana , Animais , Proteínas de Transporte/farmacologia , Quimiocina CXCL10 , Quimiocinas CXC/biossíntese , Meios de Cultura Livres de Soro , Dissacarídeos/farmacologia , Relação Dose-Resposta a Droga , Escherichia coli , Feminino , Regulação da Expressão Gênica , Interleucina-1/biossíntese , Lipídeo A/farmacologia , Receptores de Lipopolissacarídeos/genética , Receptores de Lipopolissacarídeos/farmacologia , Lipopolissacarídeos/antagonistas & inibidores , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Knockout , Monossacarídeos/farmacologia , Fator de Necrose Tumoral alfa/biossíntese
5.
Blood ; 90(4): 1673-83, 1997 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-9269788

RESUMO

Interfering with the endotoxin-mediated cytokine cascade is thought to be a promising approach to prevent septic complications in gram-negative infections. The synthetic lipid A analog SDZ MRL 953 has been shown to be protective against endotoxic shock and bacterial infection in preclinical in vivo models. As part of a trial of unspecific immunostimulation in cancer patients, we conducted a double-blind, randomized, vehicle-controlled phase I trial of SDZ MRL 953 to investigate, first, its biologic effects and safety of administration in humans and, second, its influence on reactions to a subsequent challenge of endotoxin (Salmonella abortus equi). Twenty patients were treated intravenously with escalating doses of SDZ MRL 953 or vehicle control, followed by an intravenous application of endotoxin (2 ng/kg of body weight [BW]). Administration of SDZ MRL 953 was safe and well-tolerated. SDZ MRL 953 itself increased granulocyte counts and serum levels of granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6), but not of the proinflammatory cytokines tumor necrosis factor-alpha (TNF-alpha), IL-1beta, and IL-8. Compared with vehicle control, pretreatment with SDZ MRL 953 markedly reduced the release of TNF-alpha, IL-1beta, IL-8, IL-6, and G-CSF, but augmented the increase in granulocyte counts to endotoxin. Induction of tolerance to the endotoxin-mediated cascade of proinflammatory cytokines by pretreatment with SDZ MRL 953 in patients at risk may help to prevent complications of gram-negative sepsis.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Antibacterianos/uso terapêutico , Citocinas/metabolismo , Regulação para Baixo , Lipídeo A/análogos & derivados , Lipopolissacarídeos/farmacologia , Neoplasias/tratamento farmacológico , Adjuvantes Imunológicos/toxicidade , Adolescente , Adulto , Idoso , Antibacterianos/toxicidade , Toxinas Bacterianas/farmacologia , Método Duplo-Cego , Endotoxinas/farmacologia , Humanos , Interleucina-1/sangue , Interleucina-6/sangue , Interleucina-8/sangue , Lipídeo A/uso terapêutico , Lipídeo A/toxicidade , Pessoa de Meia-Idade , Neoplasias/metabolismo , Neutrófilos/efeitos dos fármacos , Estudos Prospectivos , Salmonella , Fator de Necrose Tumoral alfa/metabolismo
8.
J Immunol ; 153(11): 5230-8, 1994 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-7525728

RESUMO

LPS has been implicated in the pathogenesis of Gram-negative bacterial sepsis. Despite intensive efforts to define the LPS-signal transduction pathway, CD14 is the sole molecule clearly demonstrated to possess signaling capabilities. However, it remains unclear whether CD14 is the only LPS-signaling molecule expressed in phagocytes and how CD14-mediated signaling occurs. Compound SDZ 280.961 is a synthetic triacylated amino acid that structurally resembles the reducing sugar moiety of lipid A. SDZ 280.961 effectively stimulated TNF-alpha release from human PBMC. Co-incubation of PBMC with the specific LPS inhibitor Rhodobacter sphaeroides lipid A inhibited SDZ 280.961-mediated stimulation of TNF-alpha release, indicating that this analogue signals mononuclear cells via a LPS-activated signaling pathway. Induction of TNF-alpha release from mononuclear cells by SDZ 280.961 was strongly dependent on the presence of serum and was enabled by the presence of purified LPS-binding protein, characteristics of CD14-mediated signaling. In contrast, SDZ 280.961-mediated signaling was not inhibited by blocking anti-CD14 mAbs. A Chinese hamster ovary fibroblast line transfected with human CD14, which responds to LPS in a manner qualitatively similar to that of macrophage cell lines, failed to respond to SDZ 280.961. Taken together, these data suggest that the lipid A analogue SDZ 280.961 activates monocytes via a unique LPS-signal transduction pathway that appears to be independent of CD14.


Assuntos
Ácido Araquidônico/metabolismo , Lipídeo A/análogos & derivados , Lipopolissacarídeos/imunologia , Transdução de Sinais/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo , Animais , Anticorpos Monoclonais , Antígenos CD/imunologia , Antígenos de Diferenciação Mielomonocítica/imunologia , Sequência de Carboidratos , Linhagem Celular , Humanos , Lipídeo A/farmacologia , Receptores de Lipopolissacarídeos , Camundongos , Dados de Sequência Molecular , Fagócitos/efeitos dos fármacos , Transdução de Sinais/imunologia , Transfecção
9.
Injury ; 25 Suppl 4: S-D35-8, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7868195

RESUMO

A modification of the standard setup of the small external fixator is presented for use mainly on the wrist. The setup used since 1988 offers further possibilities as compared with conventional application: Completely free positioning of the wrist joint for all possible six degrees of freedom, therefore: Better possibility to postpone manual reduction until the frame is applied ("modular" fixator frame, comparable to the tube-to-tube configuration of the standard external fixator), Easy correction of axial, flexural and rotational malalignment during surgery with the external fixator in situ and without changing the pin position, Easy relaxation of overdistraction postoperatively, Temporary postoperative mobilization of the wrist joint possible. Better preoperative distraction due to higher force and longer distance of the compression/distraction device. Rigid construction by using comparably short threaded K-wires and large diameter connecting bar. Less interference with peri- and postoperative imaging techniques.


Assuntos
Fixadores Externos , Fraturas Ósseas/cirurgia , Traumatismos do Punho/cirurgia , Desenho de Equipamento , Fixação de Fratura/instrumentação , Fixação de Fratura/métodos , Humanos
10.
J Immunol ; 151(9): 4476-85, 1993 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-7691950

RESUMO

Two cell types, monocytes/macrophages and neutrophilic granulocytes, play a prominent role in the pathogenic effects of endotoxins during Gram-negative infections. We previously established that nanomolar concentrations of LPS induce the expression of new specific LPS-binding sites (LpsR) in bone marrow granulocytes of LPS-responsive mice. To examine this induction process further, we asked whether it, like other LPS activities, can be mediated by TNF-alpha. We report that exogenous rTNF-alpha can induce LpsR expression in bone marrow cells (BMC) from both LPS-responsive (C3H/HeOU) and LPS-hyporesponsive (C3H/HeJ) mice. In BMC, LPS elicited a down-regulation of the TNF-alpha receptors (TNF-R) without direct binding to TNF-R. On the other hand, taxol, a microtubule stabilizer that has shown LPS mimetic activity in macrophages, was unable to elicit LpsR expression or induce TNF-R down-regulation in BMC. Thus, unlike the LPS-signaling receptor of macrophages, that of BMC is apparently not functionally associated with microtubules. The LPS-induced expression of LpsR was inhibited only partially with an anti-TNF-alpha serum, and with dexamethasone, suggesting that an autocrine activity of endogenous TNF-alpha cannot alone account for the LPS effect. Comparative analyses also indicated that dexamethasone inhibited the LPS-induced increase of LpsR, but enhanced the number of TNF-induced LpsR+ BMC. Furthermore, the synthetic lipid PPDm2 (a 1,4-bisphosphorylated and N,N-diacylated derivative of 2,3-diamino-2,3-dideoxy-D-glucose) inhibited LPS-induced, but not TNF-induced, expression of LpsR. These data show that in BMC, LPS and TNF-alpha induce LpsR expression by different mechanisms.


Assuntos
Medula Óssea/metabolismo , Lipopolissacarídeos/farmacologia , Receptores Imunológicos/biossíntese , Fator de Necrose Tumoral alfa/farmacologia , Animais , Células da Medula Óssea , Dexametasona/farmacologia , Regulação para Baixo , Feminino , Glicolipídeos/farmacologia , Receptores de Lipopolissacarídeos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Receptores Imunológicos/efeitos dos fármacos
11.
Infect Immun ; 61(8): 3518-26, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8335383

RESUMO

Rhodobacter sphaeroides lipid A (RsDPLA) and SDZ 880.431 (3-aza-lipid X-4-phosphate) are prototypic lipopolysaccharide (LPS) antagonists. Herein, we examined the ability of these structures to regulate murine macrophage tumor necrosis factor (TNF) secretion and LPS-inducible gene expression (tumor necrosis factor alpha [TNF-alpha], interleukin-1 beta [IL-1 beta], IP-10, type 2 TNF receptor [TNFR-2], D3, and D8 genes). We report that RsDPLA alone (> 1 microgram/ml) induced low levels of TNF-alpha secretion and a selective pattern of gene expression in peritoneal exudate macrophages; SDZ 880.431 alone was completely inactive. When LPS was present at a low concentration (1 ng/ml), RsDPLA and SDZ 880.431 blocked TNF secretion and gene induction in a concentration-dependent fashion. In general, gene induction was measurably reduced by 10 to 30 ng of RsDPLA per ml or 300 ng of SDZ 880.431 per ml, but inhibition could be uniformly overridden by increasing the concentration of LPS. Although induction of all six genes by LPS was suppressed by either inhibitor, effective inhibitor concentrations depended on the gene of interest. Induction of TNFR-2 by LPS was relatively resistant to inhibition by RsDPLA, and induction of TNFR-2 and D3 was relatively resistant to inhibition by SDZ 880.431. When LPS was present at > or = 100 ng/ml, correspondingly high concentrations (> or = 20 micrograms/ml) of either inhibitor influenced gene expression in a bidirectional manner. Under these conditions, LPS-induced expression of IP-10, D3, and D8 was suppressed regardless of the LPS concentration used (concentrations tested up to 50 micrograms/ml), while expression of TNF-alpha mRNA was enhanced about fourfold. In toto, RsDPLA and SDZ 880.431, when present at low concentrations, act in a manner consistent with competitive inhibition of LPS, while at higher concentrations, these structures inhibit certain LPS responses noncompetitively and synergize with LPS for other responses.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Lipídeo A/análogos & derivados , Lipopolissacarídeos/antagonistas & inibidores , Macrófagos/metabolismo , Rhodobacter sphaeroides/química , Animais , Feminino , Lipídeo A/farmacologia , Macrófagos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C3H , Ativação Transcricional , Fator de Necrose Tumoral alfa/metabolismo
12.
J Exp Med ; 178(2): 695-702, 1993 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-8101863

RESUMO

Taxol is the prototype of a new class of microtubule stabilizing agents with promising anticancer activity. Several studies show that taxol mimics the actions of lipopolysaccharide (LPS) on murine macrophages. To investigate the mechanism of taxol-induced macrophage stimulation, we evaluated the ability of Rhodobacter sphaeroides diphosphoryl lipid A (RsDPLA) and SDZ 880.431 to block taxol-induced effects. RsDPLA and SDZ 880.431 are lipid A analogues that lack LPS-like activity, but inhibit the actions of LPS, presumably by blocking critical cellular binding sites. We report that RsDPLA and SDZ 880.431 potently inhibited taxol-induced TNF secretion, gene activation, and protein-tyrosine phosphorylation. The role of microtubules in taxol signaling was investigated. Taxol-induced microtubule bundling in primary and transformed RAW 264.7 macrophages was not blocked by RsDPLA or SDZ 880.431. Taxotere, a semisynthetic taxoid, was more potent than taxol as an inducer of microtubule bundling, but did not induce tumor necrosis factor alpha secretion and gene activation. These data dissociate the microtubule effects of taxol from macrophage stimulation and suggest that taxol stimulates macrophages through an LPS receptor-dependent mechanism. The results underscore the potential of taxol as a tool for studying LPS receptor activation and provide insights into possible therapeutic actions of this new class of drugs.


Assuntos
Lipídeo A/análogos & derivados , Macrófagos/metabolismo , Paclitaxel/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Taxoides , Animais , Antineoplásicos Fitogênicos/farmacologia , Células Cultivadas , Docetaxel , Expressão Gênica , Lipídeo A/farmacologia , Macrófagos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C3H , Microtúbulos/efeitos dos fármacos , Paclitaxel/análogos & derivados , Paclitaxel/farmacologia , Fosforilação , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismo , Tirosina/metabolismo
13.
Infect Immun ; 61(5): 2015-23, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-7683001

RESUMO

Numerous lipid A analogs have been synthesized in an attempt to dissociate endotoxic activities from beneficial immunomodulatory activities. In the present study, we have evaluated select lipid A analogs in macrophages for their ability to induce a panel of lipopolysaccharide (LPS)-inducible genes to gain insights into the molecular mechanisms which underlie endotoxicity. We evaluated three monosaccharide lipid A analogs: SDZ MRL 953, an agonist with an improved therapeutic margin over endotoxin; SDZ 281.288, a more toxic analog; and SDZ 880.431, an analog with proven LPS-inhibitory activity. In addition, three disaccharide lipid A analogs (i.e., lipid IVA, SDZ 880.611, and SDZ 880.924) that differ in acylation and phosphorylation patterns were also examined and compared with synthetic lipid A. With the exception of SDZ 880.431, each of these structurally diverse analogs was able to induce the complete panel of LPS-inducible genes, specifically genes which encode tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta, 75-kDa type 2 TNF receptor (D7), IP-10, D3, and D8. These results underscore that macrophage stimulation by lipid A analogs is permissive to considerable structural diversity. Structures with favorable therapeutic indices (SDZ MRL 953, SDZ 880.611, and SDZ 880.924) were not different from structures with poor therapeutic indices (lipid A, lipid IVA, and SDZ 281.288) with regard to gene induction. Nonetheless, the nontoxic SDZ MRL 953 was approximately 1,000-fold less potent than synthetic lipid A at inducing TNF-alpha secretion, and perhaps this contributes to the lack of toxicity exhibited by this compound. The ability of compound SDZ 880.431 to inhibit TNF-alpha secretion induced by both SDZ MRL 953 and smooth LPS suggests that the monosaccharide and smooth LPS share a receptor or a portion thereof. A pattern of protein tyrosine phosphorylation similar to that induced by LPS was stimulated by the monosaccharide SDZ MRL 953 and SDZ 281.288 and disaccharides lipid IVA, SDZ 880.924, and SDZ 880.611, providing evidence for a common signalling pathway.


Assuntos
Endotoxinas/farmacologia , Expressão Gênica/efeitos dos fármacos , Lipídeo A/análogos & derivados , Lipídeo A/farmacologia , Lipopolissacarídeos/farmacologia , Macrófagos/fisiologia , Animais , Sequência de Carboidratos , Endotoxinas/química , Feminino , Glicolipídeos/farmacologia , Técnicas In Vitro , Interleucina-1/farmacologia , Lipídeo A/química , Camundongos , Camundongos Endogâmicos C3H , Fosfotirosina , Proteínas Tirosina Quinases/metabolismo , RNA Mensageiro/genética , Relação Estrutura-Atividade , Fatores de Tempo , Fator de Necrose Tumoral alfa/genética , Tirosina/análogos & derivados , Tirosina/metabolismo
14.
Int Immunol ; 4(4): 533-40, 1992 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1591221

RESUMO

We have studied the ability of synthetic analogs of lipid A to mimic lipopolysaccharide (LPS) for activation of 70Z/3 pre-B cells (expression of surface Igs) or to antagonize this effect. The results indicate that the presence of glucosamine (mono- or disaccharide) as a 'backbone' for the attachment of fatty acids is not necessary for activation of cells of the B lineage. Phosphate groups are not necessary either. Other structural features such as the configuration of particular asymmetric carbons, and the distance between an anionic group and an N-acyl chain, seem to be much more critical parameters for activation of B cells. Among the synthetic lipids which were unable to activate 70Z/3 cells, one compound, consisting of N,N-acylated and bisphosphorylated 2,3-dideoxy-2,3-diamino-D-glucose, behaved as a specific LPS antagonist and blocked also the activation triggered by the other synthetic inducers. The influence of the synthetic lipids on the entry of mature mouse B lymphocytes into the G1A phase of the cell cycle (cell enlargement) was also investigated. A high correlation was observed between the potency to activate pre-B cells and the ability to induce blast formation in mature B cells.


Assuntos
Linfócitos B/imunologia , Lipídeo A/análogos & derivados , Lipídeo A/imunologia , Lipopolissacarídeos/imunologia , Ativação Linfocitária/imunologia , Animais , Linfócitos B/citologia , Diferenciação Celular , Feminino , Técnicas In Vitro , Lipídeo A/química , Camundongos , Camundongos Endogâmicos C3H , Estrutura Molecular , Relação Estrutura-Atividade
16.
Infect Dis Clin North Am ; 5(4): 847-73, 1991 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1783772

RESUMO

Evidence has been presented for two potential methods of administering lipid A derivatives for the reduction of endotoxicity: 1. Use of low doses of agonists to induce early-phase tolerance for a sufficiently long period to protect patients at risk of endotoxin shock. 2. Administration of high doses of antagonists to the LPS-induced release of proinflammatory cytokines. The strengths and weaknesses of both approaches can be summarized as follows: Approach 1 appears promising for patients at risk for septicemias, based on iatrogenic induction of neutropenias or genetically caused neutropenic states, e.g., in cancer patients receiving aggressive chemotherapy or irradiation and in patients receiving immunosuppressive therapy (transplantations, myelodysplastic syndromes, and so forth.) Strengths. A long lasting effect can be expected. Broad protection against many types of infectious organisms. Strong potentiation of antibiotic chemotherapy anticipated irrespective of resistance patterns to antibiotics. Weaknesses. Only prophylactic treatment appears possible. Potential for endotoxic side-effects remains. Approach 2, the administration of LPS antagonists, appears most promising in clinical situations when interference with acute endotoxic shock symptoms subsequent to polytrauma is necessary. Strengths. Immediate onset of activity would be expected. Lower risk of side-effects. Weaknesses. Therapy may already be too late. Activity is restricted to endotoxicity, there being no anti-infectious potential. High drug levels might be required for a prolonged period. Synergism with antibiotics is not yet established. Together, these new lipid A derivatives open up new potential therapeutic avenues for the prophylaxis and therapy of septic shock, septicemias, and infections. Clinical studies will soon show whether the exciting pharmacologic effects observed in animals can be translated into humans.


Assuntos
Endotoxinas/antagonistas & inibidores , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Lipídeo A/uso terapêutico , Animais , Quimioterapia Adjuvante , Bactérias Gram-Negativas/efeitos dos fármacos , Humanos , Lipídeo A/análogos & derivados , Lipídeo A/química , Lipopolissacarídeos/química , Relação Estrutura-Atividade
17.
Gastroenterology ; 101(3): 726-33, 1991 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1860636

RESUMO

Colon carcinoma is one of the most frequent causes of cancer death in industrialized countries. The patients generally die of the metastases. In a colon cancer rat model, the authors have shown that lipopolysaccharides from Escherichia coli induced the regression of carcinomatosis and cured 20%-30% of the rats. Some synthetic derivatives of lipid A, which are less toxic than lipopolysaccharides, were injected 14 days after the tumor cells. They induced the complete regression of peritoneal carcinomatosis consisting of numerous nodules measuring 1-5 mm in 20%-30% of rats. Only compounds with three or more hydroxymyristic acid residues were effective. In vivo effects were correlated with the capacity to induce the production of interleukin 1 and tumor necrosis factor but not with the capacity to induce macrophage-mediated cytolysis. It is therefore possible to synthesize weakly toxic derivatives of lipopolysaccharides retaining their antitumoral property in vivo.


Assuntos
Neoplasias do Colo/terapia , Lipídeo A/análogos & derivados , Animais , Neoplasias do Colo/patologia , Feminino , Interleucina-1/biossíntese , Lipídeo A/química , Lipídeo A/uso terapêutico , Macrófagos/imunologia , Masculino , Neoplasias Peritoneais/secundário , Neoplasias Peritoneais/terapia , Ratos , Fator de Necrose Tumoral alfa/biossíntese
18.
J Infect Dis ; 164(2): 383-8, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1906912

RESUMO

A hyperdynamic sepsis model was set up in seven adult baboons to evaluate neutrophil-activating peptide-1/interleukin (IL)-8 (NAP-1/IL-8), IL-1 beta, IL-6, tumor necrosis factor-alpha (TNF alpha), and IFN-gamma in plasma. By continuous intravenous administration of 10(10) cfu/kg live Escherichia coli over 8 h with additional infusion therapy (less than or equal to 50 ml/kg/h), endotoxin plasma levels of 2.7-22.3 ng/ml were observed. In plasma the kinetics of NAP-1/IL-8 and IL-6 were similar to those of IL-1 at the end of the experiment (8 h) (peak median values, 34, 4197, and 230 ng/ml, respectively). Differences were greatest for IL-6. Monocyte activation during sepsis was confirmed by elevated plasma neopterin levels (91-139 mumol/mmol of creatine). Granulocyte activation was evident from both incipient neutropenia and the massive release of neutrophil elastase into the plasma as measured by a new immunoassay (peak level, 374 ng/ml). Thus, in primate bacteremia, early TNF release is followed by a concomitant increase of NAP-1/IL-8 with plasma kinetics similar to those of IL-6 and IL-1 and accompanied by massive activation of neutrophils.


Assuntos
Infecções por Escherichia coli/sangue , Interleucina-8/sangue , Elastase Pancreática/sangue , Sepse/sangue , Animais , Biopterinas/análogos & derivados , Biopterinas/sangue , Modelos Animais de Doenças , Endotoxinas/sangue , Infecções por Escherichia coli/enzimologia , Interferon gama/sangue , Interleucina-1/sangue , Interleucina-6/sangue , Elastase de Leucócito , Masculino , Neopterina , Papio , Sepse/enzimologia , Fator de Necrose Tumoral alfa/análise
19.
Infect Immun ; 59(7): 2351-8, 1991 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1646770

RESUMO

Lipid X, a precursor in the biosynthesis of lipid A, has been claimed to possess most of the immunostimulatory activity but none of the toxicity of endotoxin. However, recent work shows that synthetic lipid X can be contaminated with small amounts of N,O-acylated disaccharide-1-phosphate (H. Aschauer, A. Grob, J. Hildebrandt, E. Schuetze, and P. Steutz, J. Biol. Chem. 265:9159-9164, 1990). Because the impurities themselves exhibit immunostimulatory properties, it was necessary to establish whether chemically pure synthetic lipid X exhibits any of the endotoxinlike biological activities previously attributed to the native compound extracted from the Escherichia coli MN7 mutant. In the present study, two batches of synthetic lipid X were used: batch A contained the contaminating disaccharide, and batch B was pure lipid X. Batch A, previously believed to be pure on the basis of spectroscopic and microanalysis data, induced murine peritoneal macrophages to secrete tumor necrosis factor, interleukin-1, and prostaglandin E2 at a minimal dose of 10 micrograms/ml in vitro. Batch B, further purified by Sephadex LH 20 chromatography, was found virtually inactive in these in vitro assays. Furthermore, batch A was pyrogenic in rabbits at a dose of 0.05 mg/kg, whereas batch B was not pyrogenic at doses of up to greater than or equal to 2 mg/kg. However, both batches were equally tolerated by galactosamine-loaded mice at doses of up to 100 mg/kg. Surprisingly, while only batch A protected neutropenic mice against lethal infection with Pseudomonas aeruginosa (50% effective dose, 12.4 mg/kg), both batches were equally protective against infection with herpes simplex virus type 1 in mice and guinea pigs, even when lipid X was administered therapeutically. Interestingly, both batches of lipid X blocked endotoxin-induced expression of monocyte procoagulant activity and priming of human neutrophils for superoxide anion release. Similarly, both batches protected galactosamine-sensitized mice from otherwise lethal endotoxemia when administered prophylactically or simultaneously with the lipopolysaccharide challenge. Thus, our findings suggest that chemically pure lipid X (batch B) is devoid of the immunostimulatory properties of lipid A or endotoxin. Rather, it behaves as a competitive inhibitor of lipopolysaccharide. We conclude, therefore, that previous studies which attributed immunostimulatory activities to any batch of synthetic lipid X should be interpreted with caution.


Assuntos
Endotoxinas/antagonistas & inibidores , Glicolipídeos/imunologia , Adjuvantes Imunológicos , Animais , Antivirais , Dinoprostona/biossíntese , Dissacarídeos/imunologia , Relação Dose-Resposta a Droga , Feminino , Galactosamina/toxicidade , Glicolipídeos/síntese química , Glicolipídeos/farmacologia , Humanos , Técnicas In Vitro , Interleucina-1/biossíntese , Teste do Limulus , Macrófagos/fisiologia , Camundongos , Camundongos Endogâmicos , Monócitos/fisiologia , Neutrófilos/fisiologia , Pirogênios , Coelhos , Fenômeno de Shwartzman , Fosfatos Açúcares/imunologia , Superóxidos/metabolismo , Fator de Necrose Tumoral alfa/biossíntese
20.
Eur J Biochem ; 198(2): 459-69, 1991 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-2040305

RESUMO

The chemical structure of Campylobacter jejuni CCUG 10936 lipid A was elucidated. The hydrophilic backbone of the lipid A was shown to consist of three (1----6)-linked bisphosphorylated hexosamine disaccharides. Neglecting the phosphorylation pattern, a D-glucosamine (2-amino-2-deoxy-D-glucose) disaccharide [beta-D-glucosaminyl-(1----6)-D-glucosamine], a hybrid disaccharide of 2,3-diamino-2,3-dideoxy-D-glucose and D-glucosamine [2,3-diamino-2,3-dideoxy-beta-D-glucopyranosyl-(1----6)-D-glucosamine], and a 2,3-diamino-2,3-dideoxy-D-glucose disaccharide were present in a molar ratio of 1:6:1.2. Although the backbones are bisphosphorylated, heterogeneity exists in the substitution of the polar head groups. Phosphorylethanolamine is alpha-glycosidically bound to the reducing sugar residue of the backbone, though C-1 is also non-stoichiometrically substituted by diphosphorylethanolamine. Position 4' of the non-reducing sugar residue carries an ester-bound phosphate group or is non-stoichiometrically substituted by diphosphorylethanolamine. By methylation analysis it was shown that position 6' is the attachment site for the polysaccharide moiety in lipopolysaccharide. These backbone species carry up to six molecules of ester- and amide-bound fatty acids. Four molecules of (R)-3-hydroxytetradecanoic acid are linked directly to the lipid A backbone (at positions 2, 3, 2', and 3'). Laser desorption mass spectrometry showed that both (R)-3-hydroxytetradecanoic acids linked to the non-reducing sugar unit carry, at their 3-hydroxyl group, either two molecules of hexadecanoic acid or one molecule of tetradecanoic and one of hexadecanoic acid. It also suggested that the (R)-3-(tetradecanoyloxy)-tetradecanoic acid was attached at position 2', whereas (R)-3-(hexadecanoyloxy)-tetradecanoic acid was attached at position 3', or at positions 2' and 3'. Therefore, the occurrence of three backbone disaccharides differing in amino sugar composition and presence of a hybrid disaccharide differentiate the lipid A of this C. jejuni strain from enterobacterial and other lipids A described previously.


Assuntos
Campylobacter jejuni/imunologia , Glucosamina/análogos & derivados , Glucosamina/análise , Lipídeo A/química , Lipopolissacarídeos/química , Campylobacter jejuni/classificação , Configuração de Carboidratos , Sequência de Carboidratos , Ácidos Graxos/análise , Lipídeo A/isolamento & purificação , Lipopolissacarídeos/isolamento & purificação , Espectroscopia de Ressonância Magnética/métodos , Espectrometria de Massas/métodos , Metilação , Dados de Sequência Molecular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...